A medical oncologist and hematologist, Dr. Tehrani is a renowned oncologist and diagnostician whose opinion and expertise have been helping patients in diagnosing and designing tailored treatment plans for the most-complicated cases.
Having most recently served as the Director of Education and Research at Stanford Cancer Center South Bay as well as a Clinical Assistant Professor at Stanford Medicine, Dr. Tehrani brings advanced diagnostic, therapeutic and systemic treatments, including chemotherapy, targeted therapy, immunotherapy, and antibody drug conjugates to your care.
Such treatments may include systemic treatments such as chemo-free regimen, intravenous and oral chemotherapies, targeted therapy, immunotherapy, monoclonal antibodies and antibody drug conjugates.
As critical as are precise diagnosis and therapeutic techniques, your overall emotional health, perception of your health status and expectations are equally so. Dr. Tehrani and his team are well-attuned to the emotional impacts that both diagnoses and treatments can have on the patient and their loved ones. As a result, Dr. Tehrani and the Serenity team like to take a more-holistic approach to the care of their patients.
most cancer patients need a specific set of tests performed at the time of diagnosis and/or after. These may include different types of blood tests and certain imaging techniques based on the type of disease.
These are the major categories of local treatments among many others. Local treatments are more commonly applied in earlier stages of tumor removal and cancers. When proper, these techniques may be applied to early cancer treatment or find an application in more advanced cancers. There are some other techniques that are used locally.
This group includes topical, oral or injectable agents that that are commonly used to treat neoplastic processes including cancer. These agents can have some other applications including controlling autoimmune diseases or to control high counts of blood cells.
These agents are generally used as single agents or combined with other agents to suppress cellular growth, including cancer growth. Some compounds might also be applicable in controlling symptoms of other diseases.
these agents are dealing with compounds and cells that may change the level of activity or type of reaction of the immune cells. This is a heterogenous category that historically includes topical agents, pills, and injectable compounds and cells.
Such treatments include drug delivery to the target tissues. Antibodies are proteins that are relatively and generally target specific. Therefore, they can be used to deliver the therapeutic compounds at higher concentrations to the target tissue. These agents can be used to treat cancer by delivery of treating agents to tumor cells.
These compounds include agents that can boost immune system, improve anemia, or increase platelet counts.
These include topical, oral, or injectable compounds that replace or interfere with hormonal pathways. These agents may be used in helping the bones, controlling cancer or its symptoms, or help with the blood counts among other applications.
These are mostly injectable agents that are used to either target cellular growth or change the behavior of the immune system. Among their applications are treating cancer, strengthening the bones, autoimmune disease, inflammation of the bowels, and certain neurological conditions.
These are some of the treatments that as a single agent or combination regimen, without cytotoxic chemotherapy agents. Such treatment may include monoclonal antibodies, immunotherapy, targeted therapy, hormonal therapy and combination regimen.
Please note that overall, treatments are not always applicable and therapeutic approaches should be tailored based on the patient’s disease condition. Also, there are so many other agents that are already in the market or being developed for special applications. Please always talk to the treating physician about it. Please also talk to your treating physicians about medications that you are receiving or are going to receive.
Fariba is a doctor of nurse practitioner from the University of Michigan with years of experience at various prestigious institutions, including Princeton and Stanford Universities. Her experiences include 16 years of patient care in critical care, emergency medicine, cardiothoracic surgery, and hematology-oncology.
She provides patient care at the clinic and hospital in addition to overseeing management of the clinic flow. Fariba is passionate about quality patient care and believes in a holistic approach to patient care.